FDA Releases Much-Anticipated Draft Guidance On Psychedelic Research For Mental Health Conditions Jun 23, 2023
Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of… Jun 27, 2022
